UK markets close in 3 hours 51 minutes
  • FTSE 100

    +14.45 (+0.25%)
  • FTSE 250

    +60.06 (+0.34%)
  • AIM

    -2.91 (-0.30%)

    -0.0037 (-0.34%)

    +0.0001 (+0.01%)

    +567.45 (+6.64%)
  • CMC Crypto 200

    +4.36 (+1.87%)
  • S&P 500

    -56.89 (-1.63%)
  • DOW

    -410.89 (-1.44%)

    +0.15 (+0.37%)

    -3.80 (-0.20%)
  • NIKKEI 225

    -104.09 (-0.44%)

    +27.28 (+0.11%)
  • DAX

    -33.58 (-0.26%)
  • CAC 40

    +17.09 (+0.35%)

Human Embryonic Stem Cells Market - Growth, Trends, and Forecast (2020 - 2025)

·3-min read

The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications.

New York, Sept. 23, 2020 (GLOBE NEWSWIRE) -- announces the release of the report "Human Embryonic Stem Cells Market - Growth, Trends, and Forecast (2020 - 2025)" -
In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative Medicine (CIRM), fund almost all the translational researches and regenerative medicine development in the country. It is estimated that the United States government invests around USD 800-900 million every year in stem cell research. Additionally, other factors such as the high prevalence of cardiac and malignant diseases, and rising demand for regenerative medicines are expected to drive the market.

Key Market Trends
Stem Cell Biology Research Segment is Expected to Show Better Growth in the Forecast Years

Based on the application, it is segmented into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. Stem cell biology research will show better growth, owing to the high prevalence of cardiac and malignant diseases. An article published by the ISSCR (International Society for Stem Cell Research) reported that the stem cells hold potential for the treatment of Parkinson’s disease in humans. Recently, one of the market players, International Stem Cell Corporation (ISCO), received the patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs. The patent was issued in Australia. Furthermore, to boost the pace of stem cell research, the government is providing funding opportunities to researchers. Thus, owing to these factors, the market studied is expected to witness a high growth rate over the forecast period.

North America Dominates the Human Embryonic Stem Cells Market

The human embryonic stem cells market is expected to dominate in the North America region owing to extensive research activities, along with high burden of chronic diseases and genetic disorders in the region. The United States also shows a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have high potential for use in treatment and may become a standard of care for these diseases. Additionally, the FDA has approved clinical trials, which indicated the use of stem cells. Hence, these factors are expected to influence the growth of the human embryonic stem cells market over the forecast period.

Competitive Landscape
The global players into the human embryonic stem cells market are Astellas Pharma Inc, PeproTech Inc, Lineage Cell Therapeutics Inc, Merck KGaA, PromoCell GmbH, STEMCELL Technologies Inc, Thermo Fisher Scientific and ViaCyte, Inc.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001